-
Medtronic TYRX(TM) Antibacterial Envelope Reduces Cardiac Device Infection Rates at 12 Months
Medtronic TYRX(TM) Antibacterial Envelope Reduces Cardiac Device Infection Rates at 12 Months Long-term Citadel/Centurion Clinical Trial Findings and Independent DataPresented at Heart Rhythm...
-
ZELTIQ(R) Aesthetics Reaches 2,000,000th CoolSculpting(R) Treatment Cycle Milestone
ZELTIQ(R) Aesthetics Reaches 2,000,000th CoolSculpting(R) Treatment Cycle Milestone CoolSculpting Procedure Continues to Grow Noninvasive Fat Reduction Market PLEASANTON, CA– (Marketwired) –05/14/15–ZELTIQAesthetics, Inc.(NASDAQ: ZLTQ),...
-
Expert Presented Significant Body of Data from Randomized Controlled Trials of EndoGastric Solutions®’ Transoral Incisionless Fundoplication (TIF) Procedure for GERD at SAGES 2015
Expert Presented Significant Body of Data from Randomized Controlled Trials of EndoGastric Solutions Transoral Incisionless Fundoplication (TIF) Procedure for GERD at SAGES 2015...
-
CoolSculpting(R) Procedure Named “Best Non-Surgical Procedure” by JEZEBEL Magazine
CoolSculpting(R) Procedure Named “Best Non-Surgical Procedure” by JEZEBEL Magazine ATLANTA, GA– (Marketwired) –04/08/15– ZELTIQAesthetics, Inc.(NASDAQ: ZLTQ), a medical technology company focused on developing...
-
Cardiac Dimensions Completes $43M Equity Financing
Cardiac Dimensions Completes $43M Equity Financing $15.2 Million Infusion from International Investors Rounds Out Financing; Funds Will Support Landmark Trial, Expand Commercial Operations...
-
ZELTIQ Announces Fourth Quarter and Full Year 2014 Financial Results
ZELTIQ Announces Fourth Quarter and Full Year 2014 Financial Results Full Year 2014 Revenue of $174.5 million, Up 56% Year-Over-Year; Increases Full Year...
-
EndoGastric Solutions Announces Publication of Landmark Data in Gastroenterology Demonstrating Superiority of Transoral Incisionless Fundoplication For Treatment of Troublesome Regurgitation
EndoGastric Solutions Announces Publication of Landmark Data in Gastroenterology Demonstrating Superiority of Transoral Incisionless Fundoplication For Treatment of Troublesome Regurgitation January 21, 2015...
-
Cardiac Dimensions Announces New Long-Term Outcomes Data From TITAN II Clinical Trial Demonstrates Safety, Efficacy Of Enhanced CARILLON Mitral Contour System
Cardiac Dimensions Announces New Long-Term Outcomes Data From TITAN II Clinical Trial Demonstrates Safety, Efficacy Of Enhanced CARILLON Mitral Contour System Third Multi-Center...
-
Maker of Device to Help Improve Breathing Seeks $2.5M
Maker of Device to Help Improve Breathing Seeks $2.5M Posted inMedical Venture Capitalby Arundhati Parmar on February 14, 2014 Aerin Medical wants to...
-
Elusys Receives $143 Million U.S. Contract
ELUSYS receives contract FOR UP TO $143 mILLION from the U.S. Federal government to fund advanced development of Anthim, a new treatment for...
-
Heat Biologics Launch (Miami Herald)
Cancer Vaccine Deal Reached The University of Miami Medical School and a venture capital firm have started a company to develop a lung...
-
Seed-One Launches Heat Biologics
UM Partners with Seed-One Ventures to Form New Company to Develop and Market Broad-Based Therapies for Cancer and Other Diseases Miami, FL July...
-
GenOne’s Mobile Health Solution
GenerationOne to Launch Nations First Mobile Collaborative Care Solution MIAMI, Fla. (July 8, 2008) GenerationOne, Inc., is gearing up to launch the nations...
-
Seed-One Launches GenerationOne
Seed-One Ventures Launches GenerationOne New venture is focused on utilizing advanced mobile technologies to providecollaborative health care. MIAMI, Fla. (April 10, 2006) Seed-One...
-
Inventing Millionaires (Village Voice)
Inventing Millionaires Silicon Alley Duo Turn Scientists Into Fat Cats published: August 29, 2000 – Jeff Wolf and Jeff Himawan are perhaps the...